Summa Reports First-In-Man Experience
CAMBRIDGE, Massachusetts, January 17, 2024— Summa Therapeutics, LLC announced today that the first-in-man injectable angioplasty procedures for patients with below-knee peripheral arterial disease (PAD) were performed successfully using its Finesse InjectableTM angioplasty balloon catheter platform. The Summa Finesse Injectable catheter is the industry’s first hybrid diagnostic and therapeutic angioplasty balloon catheter developed to facilitate treatment…
Read more